Application of ultra-performance columns in high-performance liquid chromatography for determination of albendazole and its metabolites in turkeys

Biomedical Chromatography

Volumn 25, Issue 10, 2011, Pages 1159-1167

  Grabowski, Tomasz ^a   Jaroszewski, Jerzy Jan ^b   Świerczewska, Anna ^a   Sawicka, Renata ^a   Maślanka, Tomasz ^b   Markiewicz, Włodzimierz ^b   Ziółkowski, Hubert ^b  

^a Centre of Pharmacokinetics Research FILAB   (Poland)

^b UNIVERSITY OF WARMIA AND MAZURY IN OLSZTYN   (Poland)

Author keywords

Albendazole; HPLC; Pharmacokinetics; Ricobendazole; Turkeys; UPLC

Indexed keywords

BLOOD; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; METABOLITES; QUALITY CONTROL;

ALBENDAZOLE; ALBENDAZOLE SULFONE; ALBENDAZOLE SULFOXIDE; BLOOD PLASMA; CHROMATOGRAPHY COLUMNS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY COLUMNS; HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY; RICOBENDAZOLE; TURKEY; ULTRA PERFORMANCE LIQUID CHROMATOGRAPHY;

PHARMACOKINETICS;

ALBENDAZOLE; ALBENDAZOLE SULFONE; ALBENDAZOLE SULFOXIDE;

ANIMAL EXPERIMENT; ARTICLE; DRUG BLOOD LEVEL; DRUG DETERMINATION; DRUG ELIMINATION; DRUG HALF LIFE; DRUG STABILITY; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; INTERMETHOD COMPARISON; MAXIMUM PLASMA CONCENTRATION; NONHUMAN; QUALITY CONTROL; TURKEY (BIRD); ULTRA PERFORMANCE LIQUID CHROMATOGRAPHY;

AVES;

EID: 80052552666     PISSN: 02693879     EISSN: 10990801     Source Type: Journal    
DOI: 10.1002/bmc.1588     Document Type: Article

References (31)

1. Bettencourt PS, Capece GL and Virkel CE. Lanusse Enantiomeric behaviour of albendazole and fenbendazole sulfoxides in domestic animals: pharmacological implications. The Veterinary Journal 2009; 181: 241-250.
2. Bonato PS, Lanchote VL and Takayanagui OM. Simultaneous liquid chromatography-tandem mass spectrometric determination of albendazole sulfoxide and albendazole sulfone in plasma. Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences 2003; 783: 237-245.
3. Bonato PS, de Oliveira AR, de Santana FJ, Fernandes BJ, Lanchote VL, Gonzalez AE, Garcia HH and Takayanagui OM. Simultaneous determination of albendazole metabolites, praziquantel and its metabolite in plasma by high-performance liquid chromatography-electrospray mass spectrometry. Journal of Pharmaceutical and Biomedical Analysis 2007; 44: 558-563.
4. Callait MP, Granier C, Chauve C and Zenner L. In vitro activity of therapeutic drugs against Histomonas meleagridis (Smith, 1895). Poultry Science 2002; 81: 1122-1127.
5. Capece BP, Virkel GL and Lanusse CE. Enantiomeric behaviour of albendazole and fenbendazole sulfoxides in domestic animals: pharmacological implications. Veterinary Journal 2009; 181: 241-250.
6. Chen X, Zhao L, Xu H and Zhong D. Simultaneous determination of albendazole and its major active metabolite in human plasma using a sensitive and specific liquid chromatographic-tandem mass spectrometric method. Journal of Pharmaceutical and Biomedical Analysis 2004; 35: 829-836.
7. Danaher M, De Ruyck H, Crooks SR, Dowling G and O'Keeffe M. Review of methodology for the determination of benzimidazole residues in biological matrices. Journal of Chromatography B, Analytical Technologies in the Biomedical and Life Sciences 2007; 845: 1-37.
8. Dayan AD. Albendazole, mebendazole and praziquantel. Review of non-clinical toxicity and pharmacokinetics. Acta Tropica 2003; 86: 141-159.
9. EMEA. Note for Guidance on the Investigation of Bioavailability and Bioequivalence. CPMP/EWP/QWP/1401/98, 2001.
10. EMEA Committee For Medicinal Products For Veterinary Use. Flubendazole (Extrapolation to Poultry). EMEA/CVMP/33128/2006, 2006; 1-6.
11. FDA and CDER. Guidance for Industry Analytical Procedures and Methods Validation. Food and Drug Administration, Center for Drug Evaluation and Research: Rockville, MD, 2000.
12. FDA and CDER. Guidance for Industry: Bioanalytical Method Validation. US Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research: Rockville, MD, 2001.
13. Garrido Frenich A, Aguilera-Luiz Mdel M, Martínez Vidal JL and Romero-González R. Comparison of several extraction techniques for multiclass analysis of veterinary drugs in eggs using ultra-high pressure liquid chromatography-tandem mass spectrometry. Analytica Chimica Acta 2010; 661: 150-160.
14. Gokbulut C, Bilgili A, Hanedan B and McKellar QA. Comparative plasma disposition of fenbendazole, oxfendazole and albendazole in dogs. Veterinary Parasitology 2007; 148: 279-287.
15. Hegngi FN, Doerr J, Cummings TS, Schwartz RD, Saunders G, Zajac A, Larsen CT and Pierson FW. The effectiveness of benzimidazole derivatives for the treatment and prevention of histomonosis (blackhead) in turkeys. Veterinary Parasitology 1999; 81: 29-37.
16. Jung H, Hurtado M, Sanchez M, Medina MT and Sotelo J. Clinical pharmacokinetics of albendazole in patients with brain cysticercosis. Journal of Clinical Pharmacology 1992; 32: 28-31.
17. Jung H, Medina L, García L, Fuentes I and Moreno-Esparza R. Absorption studies of albendazole and some physicochemical properties of the drug and its metabolite albendazole sulphoxide. The Journal of Pharmacy and Pharmacology 1998; 50: 43-48.
18. ICH. Text on Validation of Analytical Procedures Q2A. International Conference on Harmonization, 1994.
19. Kaufmann A, Butcher P, Maden K and Widmer M. Ultra-performance liquid chromatography coupled to time of flight mass spectrometry (UPLC-TOF): a novel tool for multiresidue screening of veterinary drugs in urine. Analytica Chimica Acta 2007; 586: 13-21.
20. Kitzman D, Cheng KJ and Fleckenstein L. HPLC assay for albendazole and metabolites in human plasma for clinical pharmacokinetic studies. Journal of Pharmaceutical and Biomedical Analysis 2002; 30: 801-813.
21. Merino G, Molina AJ, García JL, Pulido MM, Prieto JG and Alvarez AI. Intestinal elimination of albendazole sulfoxide: pharmacokinetic effects of inhibitors. International Journal of Pharmaceutics 2003; 263: 123-132.
22. Mirfazaelian A, Dadashzadeh S and Rouini MR. A high performance liquid chromatography method for simultaneous determination of albendazole metabolites in human serum. Journal of Pharmaceutical and Biomedical Analysis 2002; 30: 1249-1254.
23. Molina AJ, Merino G, Prieto JG, Real R, Mendoza G and Alvarez AI. Absorption and metabolism of albendazole after intestinal ischemia/reperfusion. European Journal of Pharmaceutical Sciences 2007; 31: 16-24.
24. Moreno L, Echevarria F, Muñoz F, Alvarez L, Sanchez Bruni S and Lanusse C. Dose-dependent activity of albendazole against benzimidazole-resistant nematodes in sheep: relationship between pharmacokinetics and efficacy. Experimental Parasitology 2004; 106: 150-157.
25. Navarro M, Cristòfol C, Manesse M, Sautet J, Carretero A, Pérez-Aparicio FJ, Arboix M and Ruberte J. Study of the distribution of albendazole-sulphoxide (ABZ-SO) in fertilized egg compartments. Journal of Pharmacological and Toxicological Methods 1997; 37: 191-196.
26. Ortelli D, Cognard E, Jan P and Edder P. Comprehensive fast multiresidue screening of 150 veterinary drugs in milk by ultra-performance liquid chromatography coupled to time of flight mass spectrometry. Journal of Chromatography B, Analytical Technologies in the Biomedical and Life Sciences 2009; 877: 2363-2374.
27. Valois ME, Takayanagui OM, Bonato PS, Lanchote VL and Carvalho D. Determination of albendazole metabolites in plasma by HPLC. Journal of Analytical Toxicology 1994; 18: 86-90.
28. Vuitton DA. Benzimidazoles for the treatment of cystic and alveolar echinococcosis: what is the consensus? Expert Review of Anti-infective Therapy 2009; 7: 145-149.
29. Wu Z, Medlicott NJ, Razzak M and Tucker IG. Development and optimization of a rapid HPLC method for analysis of ricobendazole and albendazole sulfone in sheep plasma. Journal of Pharmaceutical and Biomedical Analysis 2005; 39: 225-232.
30. Yazwinski TA, Rosenstein M, Schwartz RD, Wilson K and Johnson Z. The use of fenbendazole in the treatment of commercial turkeys infected with Ascaridia dissimilis. Avian Pathology 1993; 22: 177-181.
31. Yazwinski TA, Tucker C, Stelzleni A, Johnson Z, Robins J, Downum K, Fincher M, Matlock J and Chapman HD. Subclinical effects and fenbendazole treatment of turkey ascaridiasis under simulated field conditions. Avian Diseases 2002; 46:886-892.